The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Oral Session

Oral Session 2-11B AML: Novel therapeutic targets

Sat. Oct 13, 2018 10:10 AM - 11:10 AM No.11 (Osaka International Convention Center, 10F 1004-5)

Chair: Yoichi Imai (Research Hospital, The Instisute of Medical Science, The University of Tokyo, Japan)

[OS2-11B-6] E3 ubiquitin ligases DTX2 and RNF38 modulate the activities of transcription factor RUNX1

Taishi Yonezawa1, Hirotaka Takahashi2, Shiori Shikata1, Tomofusa Fukuyama1, Yosuke Tanaka1, Kenneth Kassenbrock3, Tatsuya Sawasaki2, Toshio Kitamura1, Susumu Goyama1 (1.The institute of Medical Science, The University of Tokyo, Japan, 2.Proteo-Science Center (PROS)., Ehime University., Ehime, Japan, 3.Department of Pathlogy, The Univeresity of Colorado Anschutz Medical Campus)

Abstract password authentication.
Password is written on a program and abstract book.

Password